David Morrow to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications David Morrow has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.484
-
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. Diabetes Obes Metab. 2017 07; 19(7):962-969.
Score: 0.455
-
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. 2018 03; 41(3):577-585.
Score: 0.030